Clinical Trial Update: Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating whether N-acetylcysteine and sodium bicarbonate can prevent contrast-induced acute kidney injury in patients with chronic kidney d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Tokushukai Medical Group | Conditions: Chronic Kidney Disease | Phase 3 | Status: UNKNOWN